Detalhe da pesquisa
1.
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
J Infect Dis;
227(8): 939-950, 2023 04 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36348617
2.
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.
Clin Infect Dis;
72(1): 50-60, 2021 01 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31900486
3.
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
PLoS Med;
17(5): e1003117, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32442195
4.
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.
J Virol;
91(18)2017 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28701395
5.
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.
J Infect Dis;
216(9): 1080-1090, 2017 11 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28968759
6.
Validation of complex radiotherapy techniques using polymer gel dosimetry.
Phys Med Biol;
69(6)2024 Mar 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38330494
7.
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.
Vaccines (Basel);
12(4)2024 Apr 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38675770
8.
Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study" [Vaccine: X 11 (2022) 100189].
Vaccine X;
14: 100307, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37131960
9.
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant.
Vaccines (Basel);
10(4)2022 Mar 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35455257
10.
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study.
Vaccine X;
11: 100189, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35791320
11.
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Lancet Infect Dis;
22(3): 329-340, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34826381
12.
Technical Note: On the feasibility of performing dosimetry in target and organ at risk using polymer dosimetry gel and thermoluminescence detectors in an anthropomorphic, deformable, and multimodal pelvis phantom.
Med Phys;
48(9): 5501-5510, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34260079
13.
Technical Note: ADAM PETer - An anthropomorphic, deformable and multimodality pelvis phantom with positron emission tomography extension for radiotherapy.
Med Phys;
48(4): 1624-1632, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33207020
14.
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
Wien Klin Wochenschr;
133(17-18): 931-941, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34378087
15.
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.
Lancet HIV;
7(10): e688-e698, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33010242
16.
Mice lacking the nuclear pore complex protein ALADIN show female infertility but fail to develop a phenotype resembling human triple A syndrome.
Mol Cell Biol;
26(5): 1879-87, 2006 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16479006
17.
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
PLoS One;
13(11): e0206838, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496299
18.
Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI.
PLoS One;
12(8): e0183329, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28817656
19.
Technical Note: Radiological properties of tissue surrogates used in a multimodality deformable pelvic phantom for MR-guided radiotherapy.
Med Phys;
43(2): 908-16, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26843251
20.
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
PLoS One;
11(5): e0155702, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27192151